Pathogenesis of Obstructive Sleep Apnea in Obesity

Chapter
First Online:
Part of the Respiratory Medicine book series (RM, volume 19)

Abstract

Obstructive sleep apnea is a sleep-related breathing disorder characterized by repetitive upper airway obstruction and is associated with significant morbidity and mortality. Obesity is one of the primary modifiable risk factors for the management of patients with sleep apnea as there is a positive association between the increasing obesity prevalence and sleep apnea prevalence. Several mechanisms link obesity and sleep apnea pathogenesis, including the potential increase in additional mechanical load on the upper and lower respiratory systems from regional adiposity, possible effects of obesity-related inflammation on neuromuscular and neuroventilatory function of the upper airway, or a combination of these effects. By examining the relationship between obesity and obstructive sleep apnea as well as the mechanisms by which obesity may contribute to the development of sleep apnea and its related comorbidities, we can evaluate the effect of weight reduction on the management of sleep apnea.

Keywords

Sleep apnea risk factors Regional adiposity Upper airway pathophysiology Pharynx Weight loss Sleep-disordered breathing treatments Constant positive air pressure Bariatric surgery 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O’Connor GT, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;6: e1000132.PubMedGoogle Scholar
  2. 2.
    Punjabi NM. Do sleep disorders and associated treatments impact glucose metabolism? Drugs. 2009;69(Suppl 2):13–27.PubMedGoogle Scholar
  3. 3.
    Quan SF, Wright R, Baldwin CM, Kaemingk KL, Goodwin JL, Kuo TF, et al. Obstructive sleep apnea-hypopnea and neurocognitive functioning in the Sleep Heart Health Study. Sleep Med. 2006;7(6):498–507.PubMedGoogle Scholar
  4. 4.
    Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–5.PubMedGoogle Scholar
  5. 5.
    Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284:3015–21.PubMedGoogle Scholar
  6. 6.
    Hiestand DM, Britz P, Goldman M, Phillips B. Prevalence of symptoms and risk of sleep apnea in the US population: results from the national sleep foundation sleep in America 2005 poll. Chest. 2006;130:780–6.PubMedGoogle Scholar
  7. 7.
    Kyzer S, Charuzi I. Obstructive sleep apnea in the obese. World J Surg. 1998;22:998–1001.PubMedGoogle Scholar
  8. 8.
    Iber C, Ancoli-Israel S, Chesson AL, Quan SF. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1st ed. Westchester: American Academy of Sleep Medicine; 2007.Google Scholar
  9. 9.
    Olsen KD, Suh KW, Staats BA. Surgically correctable causes of sleep apnea syndrome. Otolaryngol Head Neck Surg. 1981;89:726–31.PubMedGoogle Scholar
  10. 10.
    Svanborg E, Guilleminault C. EEG frequency changes during sleep apneas. Sleep. 1996;19: 248–54.PubMedGoogle Scholar
  11. 11.
    Smurra MV, Dury M, Aubert G, Rodenstein DO, Liistro G. Sleep fragmentation: comparison of two definitions of short arousals during sleep in OSAS patients. Eur Respir J. 2001;17: 723–7.PubMedGoogle Scholar
  12. 12.
    Martin SE, Engleman HM, Deary IJ, Douglas NJ. The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med. 1996;153:1328–32.PubMedGoogle Scholar
  13. 13.
    Redline S, Strohl KP. Recognition and consequences of obstructive sleep apnea hypopnea syndrome. Clin Chest Med. 1998;19:1–19.PubMedGoogle Scholar
  14. 14.
    Bearpark H, Grunstein R, Touyz S. Cognitive and psychological dysfunction in sleep apnea before and after treatment with CPAP. Sleep Res. 1987;16:303.Google Scholar
  15. 15.
    Sforza E, Roche F, Thomas-Anterion C, Kerleroux J, Beauchet O, Celle S, et al. Cognitive function and sleep related breathing disorders in a healthy elderly population: the SYNAPSE study. Sleep. 2010;33:515–21.PubMedGoogle Scholar
  16. 16.
    Canet E, Castronovo V, Capp SF, Aloia MS, Marelli S, Falini A. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med. 2011;183(10):1419–26.Google Scholar
  17. 17.
    Roth T, Roehrs T, Zorick F, Conway W. Pharmacological effects of sedative-hypnotics, narcotic analgesics, and alcohol during sleep. Med Clin North Am. 1985;69:1281–8.PubMedGoogle Scholar
  18. 18.
    Hack MA, Choi SJ, Vijayapalan P, Davies RJ, Stradling JR. Comparison of the effects of sleep deprivation, alcohol and obstructive sleep apnoea (OSA) on simulated steering performance. Respir Med. 2001;95:594–601.PubMedGoogle Scholar
  19. 19.
    McNicholas WT, Tarlo S, Cole P, Zamel N, Rutherford R, Griffin D, et al. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis. 1982;126:625–8.PubMedGoogle Scholar
  20. 20.
    Rajala R, Partinen M, Sane T, Pelkonen R, Huikuri K, Seppalainen AM. Obstructive sleep apnoea syndrome in morbidly obese patients. J Intern Med. 1991;230:125–9.PubMedGoogle Scholar
  21. 21.
    Richman RM, Elliott LM, Burns CM, Bearpark HM, Steinbeck KS, Caterson ID. The prevalence of obstructive sleep apnoea in an obese female population. Int J Obes Relat Metab Disord. 1994;18:173–7.PubMedGoogle Scholar
  22. 22.
    Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994;154:1705–11.PubMedGoogle Scholar
  23. 23.
    Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–7.PubMedGoogle Scholar
  24. 24.
    Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002;165:677–82.PubMedGoogle Scholar
  25. 25.
    Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165:1217–39.PubMedGoogle Scholar
  26. 26.
    Schwartz AR, Gold AR, Schubert N, Stryzak A, Wise RA, Permutt S, et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis. 1991;144:494–8.PubMedGoogle Scholar
  27. 27.
    Malhotra A, White DP. Obstructive sleep apnoea. Lancet. 2002;360:237–45.PubMedGoogle Scholar
  28. 28.
    Valencia-Flores M, Orea A, Castano VA, Resendiz M, Rosales M, Rebollar V, et al. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. Obes Res. 2000;8:262–9.PubMedGoogle Scholar
  29. 29.
    Katz I, Stradling J, Slutsky AS, Zamel N, Hoffstein V. Do patients with obstructive sleep apnea have thick necks? Am Rev Respir Dis. 1990;141:1228–31.PubMedGoogle Scholar
  30. 30.
    Legato MJ. Gender-specific aspects of obesity. Int J Fertil Womens Med. 1997;42:184–97.PubMedGoogle Scholar
  31. 31.
    Millman RP, Carlisle CC, McGarvey ST, Eveloff SE, Levinson PD. Body fat distribution and sleep apnea severity in women. Chest. 1995;107:362–6.PubMedGoogle Scholar
  32. 32.
    Shinohara E, Kihara S, Yamashita S, Yamane M, Nishida M, Arai T, et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med. 1997;241:11–8.PubMedGoogle Scholar
  33. 33.
    Haponik EF, Smith PL, Bohlman ME, Allen RP, Goldman SM, Bleecker ER. Computerized tomography in obstructive sleep apnea. Correlation of airway size with physiology during sleep and wakefulness. Am Rev Respir Dis. 1983;127:221–6.PubMedGoogle Scholar
  34. 34.
    Schwab RJ, Gupta KB, Gefter WB, Metzger LJ, Hoffman EA, Pack AI. Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls. Am J Respir Crit Care Med. 1995;152: 1673–89.PubMedGoogle Scholar
  35. 35.
    Suratt PM, Dee P, Atkinson RL, Armstrong P, Wilhoit SC. Fluoroscopic and computed tomographic features of the pharyngeal airway in obstructive sleep apnea. Am Rev Respir Dis. 1983;127:487–92.PubMedGoogle Scholar
  36. 36.
    Gleadhill IC, Schwartz AR, Schubert N, Wise RA, Permutt S, Smith PL. Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis. 1991;143:1300–3.PubMedGoogle Scholar
  37. 37.
    Isono S, Remmers JE, Tanaka A, Sho Y, Sato J, Nishino T. Anatomy of the pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol. 1997;82: 1319–26.PubMedGoogle Scholar
  38. 38.
    Isono S, Tanaka A, Tagaito Y, Sho Y, Nishino T. Respiratory stability in unconscious patients with OSA: a role of surface adhesive force. Am J Respir Crit Care Med. 1997;155(4):A413.Google Scholar
  39. 39.
    Isono S, Feroah TR, Hajduk EA, Brant R, Whitelaw WA, Remmers JE. Interaction of cross-sectional area, driving pressure, and airflow of passive velopharynx. J Appl Physiol. 1997;83:851–9.PubMedGoogle Scholar
  40. 40.
    Isono S, Tanaka A, Tagaito Y, Sho Y, Nishino T. Pharyngeal patency in response to advancement of the mandible in obese anesthetized persons. Anesthesiology. 1997;87:1055–62.PubMedGoogle Scholar
  41. 41.
    Smith PL, Wise RA, Gold AR, Schwartz AR, Permutt S. Upper airway pressure-flow ­relationships in obstructive sleep apnea. J Appl Physiol. 1988;64:789–95.PubMedGoogle Scholar
  42. 42.
    Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002;76:473–81.PubMedGoogle Scholar
  43. 43.
    Pierson Jr RN, Lin DH, Phillips RA. Total-body potassium in health: effects of age, sex, height, and fat. Am J Physiol. 1974;226:206–12.PubMedGoogle Scholar
  44. 44.
    Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724–31.PubMedGoogle Scholar
  45. 45.
    Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab. 1997;82:2396–402.PubMedGoogle Scholar
  46. 46.
    Muniyappa R, Wong KA, Baldwin HL, Sorkin JD, Johnson ML, Bhasin S, et al. Dehydroepiandrosterone secretion in healthy older men and women: effects of testosterone and growth hormone administration in older men. J Clin Endocrinol Metab. 2006;91: 4445–52.PubMedGoogle Scholar
  47. 47.
    Lee CG, Carr MC, Murdoch SJ, Mitchell E, Woods NF, Wener MH, et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab. 2009;94:1104–10.PubMedGoogle Scholar
  48. 48.
    Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr. 1992;55:950–4.PubMedGoogle Scholar
  49. 49.
    Zamboni M, Armellini F, Milani MP, De MM, Todesco T, Robbi R, et al. Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships. Int J Obes Relat Metab Disord. 1992;16:495–504.PubMedGoogle Scholar
  50. 50.
    Young T. Menopause, hormone replacement therapy, and sleep-disordered breathing: are we ready for the heat? Am J Respir Crit Care Med. 2001;163:597–8.PubMedGoogle Scholar
  51. 51.
    Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O. Sleep-disordered breathing in community-dwelling elderly. Sleep. 1991;14:486–95.PubMedGoogle Scholar
  52. 52.
    Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med. 1998;157:144–8.PubMedGoogle Scholar
  53. 53.
    Bliwise DL, Bliwise NG, Partinen M, Pursley AM, Dement WC. Sleep apnea and mortality in an aged cohort. Am J Public Health. 1988;78:544–7.PubMedGoogle Scholar
  54. 54.
    Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med. 1996;154:279–89.PubMedGoogle Scholar
  55. 55.
    Kirkness JP, Schwartz AR, Schneider H, Punjabi NM, Maly JJ, Laffan AM, et al. Contribution of male sex, age, and obesity to mechanical instability of the upper airway during sleep. J Appl Physiol. 2008;104:1618–24.PubMedGoogle Scholar
  56. 56.
    Jordan AS, Wellman A, Edwards JK, Schory K, Dover L, MacDonald M, et al. Respiratory control stability and upper airway collapsibility in men and women with obstructive sleep apnea. J Appl Physiol. 2005;99:2020–7.PubMedGoogle Scholar
  57. 57.
    Davies RJ, Stradling JR. The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome. Eur Respir J. 1990;3:509–14.PubMedGoogle Scholar
  58. 58.
    Sharp JT, Henry JP, Sweany SK, Meadows WR, Pietras RJ. Effects of mass loading the respiratory system in man. J Appl Physiol. 1964;19:959–66.PubMedGoogle Scholar
  59. 59.
    Heinzer RC, Stanchina ML, Malhotra A, Fogel RB, Patel SR, Jordan AS, et al. Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea. Am J Respir Crit Care Med. 2005;172:114–7.PubMedGoogle Scholar
  60. 60.
    Heinzer RC, Stanchina ML, Malhotra A, Jordan AS, Patel SR, Lo YL, et al. Effect of increased lung volume on sleep disordered breathing in sleep apnoea patients. Thorax. 2006;61:435–9.PubMedGoogle Scholar
  61. 61.
    Kairaitis K, Byth K, Parikh R, Stavrinou R, Wheatley JR, Amis TC. Tracheal traction effects on upper airway patency in rabbits: the role of tissue pressure. Sleep. 2007;30:179–86.PubMedGoogle Scholar
  62. 62.
    Babb TG, Wyrick BL, Delorey DS, Chase PJ, Feng MY. Fat distribution and end-expiratory lung volume in lean and obese men and women. Chest. 2008;134:704–11.PubMedGoogle Scholar
  63. 63.
    Rowley JA, Permutt S, Willey S, Smith PL, Schwartz AR. Effect of tracheal and tongue displacement on upper airway airflow dynamics. J Appl Physiol. 1996;80:2171–8.PubMedGoogle Scholar
  64. 64.
    Squier SB, Patil SP, Schneider H, Kirkness JP, Smith PL, Schwartz AR. Effect of end-expiratory lung volume on upper airway collapsibility in sleeping men and women. J Appl Physiol. 2010;109:977–85.PubMedGoogle Scholar
  65. 65.
    Whittle AT, Marshall I, Mortimore IL, Wraith PK, Sellar RJ, Douglas NJ. Neck soft tissue and fat distribution: comparison between normal men and women by magnetic resonance imaging. Thorax. 1999;54:323–8.PubMedGoogle Scholar
  66. 66.
    Koskenvuo M, Kaprio J, Partinen M, Langinvainio H, Sarna S, Heikkila K. Snoring as a risk factor for hypertension and angina pectoris. Lancet. 1985;1:893–6.PubMedGoogle Scholar
  67. 67.
    He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988;94:9–14.PubMedGoogle Scholar
  68. 68.
    Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest. 1988;94:1200–4.PubMedGoogle Scholar
  69. 69.
    Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet. 1990;336:261–4.PubMedGoogle Scholar
  70. 70.
    Basta M, Vgontzas AN. Metabolic abnormalities in obesity and sleep apnea are in a continuum. Sleep Med. 2007;8:5–7.PubMedGoogle Scholar
  71. 71.
    Redline S, Storfer-Isser A, Rosen CL, Johnson NL, Kirchner HL, Emancipator J, et al. Association between metabolic syndrome and sleep-disordered breathing in adolescents. Am J Respir Crit Care Med. 2007;176:401–8.PubMedGoogle Scholar
  72. 72.
    Jean-Louis G, Zizi F, Clark LT, Brown CD, McFarlane SI. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med. 2008;4:261–72.PubMedGoogle Scholar
  73. 73.
    Attal P, Chanson P. Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metab. 2010;95:483–95.PubMedGoogle Scholar
  74. 74.
    Chin K, Oga T, Takahashi K, Takegami M, Nakayama-Ashida Y, Wakamura T, et al. Associations between obstructive sleep apnea, metabolic syndrome, and sleep duration, as measured with an actigraph, in an urban male working population in Japan. Sleep. 2010;33:89–95.PubMedGoogle Scholar
  75. 75.
    Barbe F, Pericas J, Munoz A, Findley L, Anto JM, Agusti AG. Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study. Am J Respir Crit Care Med. 1998;158:18–22.PubMedGoogle Scholar
  76. 76.
    Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med. 1999;340:847–51.PubMedGoogle Scholar
  77. 77.
    Chami HA, Baldwin CM, Silverman A, Zhang Y, Rapoport D, Punjabi NM, et al. Sleepiness, quality of life, and sleep maintenance in REM versus non-REM sleep-disordered breathing. Am J Respir Crit Care Med. 2010;181:997–1002.PubMedGoogle Scholar
  78. 78.
    Al Lawati NM, Patel SR, Ayas NT. Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog Cardiovasc Dis. 2009;51:285–93.PubMedGoogle Scholar
  79. 79.
    Goncalves MA, Paiva T, Ramos E, Guilleminault C. Obstructive sleep apnea syndrome, sleepiness, and quality of life. Chest. 2004;125:2091–6.PubMedGoogle Scholar
  80. 80.
    Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283:1829–36.PubMedGoogle Scholar
  81. 81.
    Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–84.PubMedGoogle Scholar
  82. 82.
    Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease. Long-term prognosis. Am J Respir Crit Care Med. 2001;164: 1910–3.PubMedGoogle Scholar
  83. 83.
    Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier NF, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19–25.PubMedGoogle Scholar
  84. 84.
    Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897–904.PubMedGoogle Scholar
  85. 85.
    Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest. 1993;103:1763–8.PubMedGoogle Scholar
  86. 86.
    Narkiewicz K, Pesek CA, Kato M, Phillips BG, Davison DE, Somers VK. Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension. 1998;32:1039–43.PubMedGoogle Scholar
  87. 87.
    Carlson JT, Hedner JA, Sellgren J, Elam M, Wallin BG. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 1996;154:1490–6.PubMedGoogle Scholar
  88. 88.
    Hedner JA, Wilcox I, Laks L, Grunstein RR, Sullivan CE. A specific and potent pressor effect of hypoxia in patients with sleep apnea. Am Rev Respir Dis. 1992;146:1240–5.PubMedGoogle Scholar
  89. 89.
    Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, Somers VK. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation. 1999;99:1183–9.PubMedGoogle Scholar
  90. 90.
    Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17:61–6.PubMedGoogle Scholar
  91. 91.
    Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000;102:2607–10.PubMedGoogle Scholar
  92. 92.
    Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation. 1998;98:772–6.PubMedGoogle Scholar
  93. 93.
    Rajala MW, Scherer PE. Minireview: the adipocyte–at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003;144:3765–73.PubMedGoogle Scholar
  94. 94.
    Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue – an update. Horm Metab Res. 2007;39:314–21.PubMedGoogle Scholar
  95. 95.
    Friedman JM. Leptin, leptin receptors, and the control of body weight. Nutr Rev. 1998;56: s38–46.PubMedGoogle Scholar
  96. 96.
    Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–32.PubMedGoogle Scholar
  97. 97.
    Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292–5.PubMedGoogle Scholar
  98. 98.
    Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1:1155–61.PubMedGoogle Scholar
  99. 99.
    Breslow MJ, Min-Lee K, Brown DR, Chacko VP, Palmer D, Berkowitz DE. Effect of leptin deficiency on metabolic rate in ob/ob mice. Am J Physiol. 1999;276:E443–9.PubMedGoogle Scholar
  100. 100.
    Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387:903–8.PubMedGoogle Scholar
  101. 101.
    Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R, et al. Partial leptin deficiency and human adiposity. Nature. 2001;414:34–5.PubMedGoogle Scholar
  102. 102.
    Ravussin E, Pratley RE, Maffei M, Wang H, Friedman JM, Bennett PH, et al. Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med. 1997;3: 238–40.PubMedGoogle Scholar
  103. 103.
    Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab. 2001;280:E827–47.PubMedGoogle Scholar
  104. 104.
    Zhang HH, Kumar S, Barnett AH, Eggo MC. Dexamethasone inhibits tumor necrosis factor-alpha-induced apoptosis and interleukin-1 beta release in human subcutaneous adipocytes and preadipocytes. J Clin Endocrinol Metab. 2001;86:2817–25.PubMedGoogle Scholar
  105. 105.
    Tasali E, Leproult R, Ehrmann DA, Van CE. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci USA. 2008;105:1044–9.PubMedGoogle Scholar
  106. 106.
    Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435–9.PubMedGoogle Scholar
  107. 107.
    Chow DC, Souza SA, Chen R, Richmond-Crum SM, Grandinetti A, Shikuma C. Elevated blood pressure in HIV-infected individuals receiving highly active antiretroviral therapy. HIV Clin Trials. 2003;4:411–6.PubMedGoogle Scholar
  108. 108.
    Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet. 1998;351:1881–3.PubMedGoogle Scholar
  109. 109.
    Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia, and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12:F51–8.PubMedGoogle Scholar
  110. 110.
    Roth VR, Kravcik S, Angel JB. Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors. Clin Infect Dis. 1998;27:65–7.PubMedGoogle Scholar
  111. 111.
    Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–8.PubMedGoogle Scholar
  112. 112.
    Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346:570–8.PubMedGoogle Scholar
  113. 113.
    Mulligan K, Khatami H, Schwarz JM, Sakkas GK, DePaoli AM, Tai VW, et al. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. J Clin Endocrinol Metab. 2009;94:1137–44.PubMedGoogle Scholar
  114. 114.
    Lee JH, Chan JL, Sourlas E, Raptopoulos V, Mantzoros CS. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy. J Clin Endocrinol Metab. 2006;91:2605–11.PubMedGoogle Scholar
  115. 115.
    Yee BJ, Cheung J, Phipps P, Banerjee D, Piper AJ, Grunstein RR. Treatment of obesity hypoventilation syndrome and serum leptin. Respiration. 2006;73:209–12.PubMedGoogle Scholar
  116. 116.
    Phipps PR, Starritt E, Caterson I, Grunstein RR. Association of serum leptin with hypoventilation in human obesity. Thorax. 2002;57:75–6.PubMedGoogle Scholar
  117. 117.
    Piper AJ, Grunstein RR. Obesity hypoventilation syndrome: mechanisms and management. Am J Respir Crit Care Med. 2011;183:292–8.PubMedGoogle Scholar
  118. 118.
    Piper AJ, Grunstein RR. Big breathing: the complex interaction of obesity, hypoventilation, weight loss, and respiratory function. J Appl Physiol. 2010;108:199–205.PubMedGoogle Scholar
  119. 119.
    Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010;137:711–9.PubMedGoogle Scholar
  120. 120.
    Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol. 2005;99:1998–2007.PubMedGoogle Scholar
  121. 121.
    Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O’Donnell CP. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol. 2003;136:167–78.PubMedGoogle Scholar
  122. 122.
    Lavie L. Oxidative stress – a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis. 2009;51:303–12.PubMedGoogle Scholar
  123. 123.
    Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, et al. Chronic intermittent hypoxia predisposes to liver injury. Hepatology. 2007;45:1007–13.PubMedGoogle Scholar
  124. 124.
    Tatsumi K, Saibara T. Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatol Res. 2005;33:100–4.PubMedGoogle Scholar
  125. 125.
    Punjabi NM, O’hearn DJ, Neubauer DN, Nieto FJ, Schwartz AR, Smith PL, et al. Modeling hypersomnolence in sleep-disordered breathing. A novel approach using survival analysis. Am J Respir Crit Care Med. 1999;159:1703–9.PubMedGoogle Scholar
  126. 126.
    Gooneratne NS, Weaver TE, Cater JR, Pack FM, Arner HM, Greenberg AS, et al. Functional outcomes of excessive daytime sleepiness in older adults. J Am Geriatr Soc. 2003;51: 642–9.PubMedGoogle Scholar
  127. 127.
    Bonnet MH, Arand DL. Clinical effects of sleep fragmentation versus sleep deprivation. Sleep Med Rev. 2003;7:297–310.PubMedGoogle Scholar
  128. 128.
    Mitler MM, Carskadon MA, Czeisler CA, Dement WC, Dinges DF, Graeber RC. Catastrophes, sleep, and public policy: consensus report. Sleep. 1988;11:100–9.PubMedGoogle Scholar
  129. 129.
    Young T, Blustein J, Finn L, Palta M. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep. 1997;20:608–13.PubMedGoogle Scholar
  130. 130.
    Engleman HM, Kingshott RN, Martin SE, Douglas NJ. Cognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep. 2000;23(Suppl 4):S102–8.PubMedGoogle Scholar
  131. 131.
    Felver-Gant JC, Bruce AS, Zimmerman M, Sweet LH, Millman RP, Aloia MS. Working memory in obstructive sleep apnea: construct validity and treatment effects. J Clin Sleep Med. 2007;3:589–94.PubMedGoogle Scholar
  132. 132.
    Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet. 1994;343: 572–5.PubMedGoogle Scholar
  133. 133.
    Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax. 1998;53:341–5.PubMedGoogle Scholar
  134. 134.
    Haynes PL. The role of behavioral sleep medicine in the assessment and treatment of sleep disordered breathing. Clin Psychol Rev. 2005;25:673–705.PubMedGoogle Scholar
  135. 135.
    Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121:91–100.PubMedGoogle Scholar
  136. 136.
    Dixon JB, Schachter LM, O’Brien PE. Sleep disturbance and obesity: changes following surgically induced weight loss. Arch Intern Med. 2001;161:102–6.PubMedGoogle Scholar
  137. 137.
    Dixon JB, Dixon ME, Anderson ML, Schachter L, O’Brien PE. Daytime sleepiness in the obese: not as simple as obstructive sleep apnea. Obesity (Silver Spring). 2007;15:2504–11.Google Scholar
  138. 138.
    Schwartz AR, O’Donnell CP, Baron J, Schubert N, Alam D, Samadi SD, et al. The hypotonic upper airway in obstructive sleep apnea: role of structures and neuromuscular activity. Am J Respir Crit Care Med. 1998;157:1051–7.PubMedGoogle Scholar
  139. 139.
    Smith PL, Patil SP, Kirkness JP, Schneider H, Schwartz AR. Biomechanics of upper airway during sleep – sleep apnea: pathogenesis, diagnosis, and treatment. In: Pack AI, editor. Sleep apnea pathogenesis, diagnosis and treatment. New York: Marcel Dekker; 2011.Google Scholar
  140. 140.
    Kushida CA, Efron B, Guilleminault C. A predictive morphometric model for the obstructive sleep apnea syndrome. Ann Intern Med. 1997;127:581–7.PubMedGoogle Scholar
  141. 141.
    Riley R, Guilleminault C, Herran J, Powell N. Cephalometric analyses and flow-volume loops in obstructive sleep apnea patients. Sleep. 1983;6:303–11.PubMedGoogle Scholar
  142. 142.
    Rivlin J, Hoffstein V, Kalbfleisch J, McNicholas W, Zamel N, Bryan AC. Upper airway morphology in patients with idiopathic obstructive sleep apnea. Am Rev Respir Dis. 1984;129:355–60.PubMedGoogle Scholar
  143. 143.
    Lyberg T, Krogstad O, Djupesland G. Cephalometric analysis in patients with obstructive sleep apnoea syndrome. I. Skeletal morphology. J Laryngol Otol. 1989;103:287–92.PubMedGoogle Scholar
  144. 144.
    Bhattacharyya N, Blake SP, Fried MP. Assessment of the airway in obstructive sleep apnea syndrome with 3-dimensional airway computed tomography. Otolaryngol Head Neck Surg. 2000;123:444–9.PubMedGoogle Scholar
  145. 145.
    Kuna ST, Bedi DG, Ryckman C. Effect of nasal airway positive pressure on upper airway size and configuration. Am Rev Respir Dis. 1988;138:969–75.PubMedGoogle Scholar
  146. 146.
    Schwab RJ, Gupta KB, Metzger LJ, Pack AI, Gefter WB. State related changes in upper airway caliber and surrounding soft tissue structures in normals and apneics. Am J Respir Crit Care Med. 1995;151:A667.Google Scholar
  147. 147.
    Schwab RJ, Pack AI, Gupta KB, Metzger LJ, Oh E, Getsy JE, et al. Upper airway and soft tissue structural changes induced by CPAP in normal subjects. Am J Respir Crit Care Med. 1996;154:1106–16.PubMedGoogle Scholar
  148. 148.
    Schotland HM, Insko EK, Schwab RJ. Quantitative magnetic resonance imaging demonstrates alterations of the lingual musculature in obstructive sleep apnea. Sleep. 1999;22: 605–13.PubMedGoogle Scholar
  149. 149.
    Simpson L, Mukherjee S, Cooper MN, Ward KL, Lee JD, Fedson AC, et al. Sex differences in the association of regional fat distribution with the severity of obstructive sleep apnea. Sleep. 2010;33:467–74.PubMedGoogle Scholar
  150. 150.
    Stanchina ML, Malhotra A, Fogel RB, Trinder J, Edwards JK, Schory K, et al. The influence of lung volume on pharyngeal mechanics, collapsibility, and genioglossus muscle activation during sleep. Sleep. 2003;26:851–6.PubMedGoogle Scholar
  151. 151.
    Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes. 1996;45:633–8.PubMedGoogle Scholar
  152. 152.
    Paradisi G, Smith L, Burtner C, Leaming R, Garvey WT, Hook G, et al. Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care. 1999;22:1310–7.PubMedGoogle Scholar
  153. 153.
    Rissanen P, Hamalainen P, Vanninen E, Tenhunen-Eskelinen M, Uusitupa M. Relationship of metabolic variables to abdominal adiposity measured by different anthropometric measurements and dual-energy X-ray absorptiometry in obese middle-aged women. Int J Obes Relat Metab Disord. 1997;21:367–71.PubMedGoogle Scholar
  154. 154.
    Lee K, Lee S, Kim YJ, Kim YJ. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. Nutrition. 2008;24:625–31.PubMedGoogle Scholar
  155. 155.
    dos Santos RE, Aldrighi JM, Lanz JR, Ferezin PC, Marone MM. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women. Gynecol Endocrinol. 2005;21:295–301.PubMedGoogle Scholar
  156. 156.
    Bernstein LE, Berry J, Kim S, Canavan B, Grinspoon SK. Effects of etanercept in patients with the metabolic syndrome. Arch Intern Med. 2006;166:902–8.PubMedGoogle Scholar
  157. 157.
    Catalan V, Gomez-Ambrosi J, Ramirez B, Rotellar F, Pastor C, Silva C, et al. Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg. 2007;17:1464–74.PubMedGoogle Scholar
  158. 158.
    Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007;116:1234–41.PubMedGoogle Scholar
  159. 159.
    Yamamoto Y, Gaynor RB. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci. 2004;29:72–9.PubMedGoogle Scholar
  160. 160.
    Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002;3: 221–7.PubMedGoogle Scholar
  161. 161.
    Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 1986;47:921–8.PubMedGoogle Scholar
  162. 162.
    Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83:847–50.PubMedGoogle Scholar
  163. 163.
    Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91.PubMedGoogle Scholar
  164. 164.
    Manzella D, Parillo M, Razzino T, Gnasso P, Buonanno S, Gargiulo A, et al. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obes Relat Metab Disord. 2002;26:370–5.PubMedGoogle Scholar
  165. 165.
    Arias MA, Garcia-Rio F, Onso-Fernandez A, Hernanz A, Hidalgo R, Martinez-Mateo V, et al. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J. 2008;32:1009–15.PubMedGoogle Scholar
  166. 166.
    Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans. 2001;29:72–5.PubMedGoogle Scholar
  167. 167.
    Dusserre E, Moulin P, Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta. 2000;1500:88–96.PubMedGoogle Scholar
  168. 168.
    Fang J, Wang Y, Krueger JM. Effects of interleukin-1 beta on sleep are mediated by the type I receptor. Am J Physiol. 1998;274:R655–60.PubMedGoogle Scholar
  169. 169.
    Krueger JM, Fang J, Hansen MK, Zhang J, Obal Jr F. Humoral regulation of sleep. News Physiol Sci. 1998;13:189–94.PubMedGoogle Scholar
  170. 170.
    Krueger JM, Obal FJ, Fang J, Kubota T, Taishi P. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci. 2001;933:211–21.PubMedGoogle Scholar
  171. 171.
    Takahashi S, Kapas L, Fang J, Krueger JM. Somnogenic relationships between tumor necrosis factor and interleukin-1. Am J Physiol. 1999;276:R1132–40.PubMedGoogle Scholar
  172. 172.
    Opp MR. Cytokines and sleep. Sleep Med Rev. 2005;9:355–64.PubMedGoogle Scholar
  173. 173.
    Fang J, Wang Y, Krueger JM. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment. J Neurosci. 1997;17:5949–55.PubMedGoogle Scholar
  174. 174.
    Krueger JM, Fang J, Taishi P, Chen Z, Kushikata T, Gardi J. Sleep. A physiologic role for IL-1 beta and TNF-alpha. Ann N Y Acad Sci. 1998;856:148–59.PubMedGoogle Scholar
  175. 175.
    Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab. 2004;89:4409–13.PubMedGoogle Scholar
  176. 176.
    Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, et al. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol. 2001;107:165–70.PubMedGoogle Scholar
  177. 177.
    Churchill L, Rector DM, Yasuda K, Fix C, Rojas MJ, Yasuda T, et al. Tumor necrosis factor alpha: activity dependent expression and promotion of cortical column sleep in rats. Neuroscience. 2008;156:71–80.PubMedGoogle Scholar
  178. 178.
    O’Donnell CP, Schwartz AR, Smith PL. Upper airway collapsibility: the importance of gender and adiposity. Am J Respir Crit Care Med. 2000;162:1606–7.PubMedGoogle Scholar
  179. 179.
    Pillar G, Malhotra A, Fogel R, Beauregard J, Schnall R, White DP. Airway mechanics and ventilation in response to resistive loading during sleep: influence of gender. Am J Respir Crit Care Med. 2000;162:1627–32.PubMedGoogle Scholar
  180. 180.
    Leech JA, Onal E, Dulberg C, Lopata MA. A comparison of men and women with occlusive sleep apnea syndrome. Chest. 1988;94:983–8.PubMedGoogle Scholar
  181. 181.
    Mohsenin V. Gender differences in the expression of sleep-disordered breathing: role of upper airway dimensions. Chest. 2001;120:1442–7.PubMedGoogle Scholar
  182. 182.
    O’Connor C, Thornley KS, Hanly PJ. Gender differences in the polysomnographic features of obstructive sleep apnea. Am J Respir Crit Care Med. 2000;161:1465–72.PubMedGoogle Scholar
  183. 183.
    Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000;118:580–6.PubMedGoogle Scholar
  184. 184.
    Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105:2462–4.PubMedGoogle Scholar
  185. 185.
    Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000;85:1151–8.PubMedGoogle Scholar
  186. 186.
    Alberti A, Sarchielli P, Gallinella E, Floridi A, Floridi A, Mazzotta G, et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res. 2003;12:305–11.PubMedGoogle Scholar
  187. 187.
    Kataoka T, Enomoto F, Kim R, Yokoi H, Fujimori M, Sakai Y, et al. The effect of surgical treatment of obstructive sleep apnea syndrome on the plasma TNF-alpha levels. Tohoku J Exp Med. 2004;204:267–72.PubMedGoogle Scholar
  188. 188.
    Punjabi NM, Beamer BA. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep. 2007;30:29–34.PubMedGoogle Scholar
  189. 189.
    Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-{kappa}B-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2006;174:824–30.PubMedGoogle Scholar
  190. 190.
    Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129–34.PubMedGoogle Scholar
  191. 191.
    Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2000;279:H234–7.PubMedGoogle Scholar
  192. 192.
    Ozturk L, Unal M, Tamer L, Celikoglu F. The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg. 2003;129:538–40.PubMedGoogle Scholar
  193. 193.
    Marik PE. Leptin, obesity, and obstructive sleep apnea. Chest. 2000;118:569–71.PubMedGoogle Scholar
  194. 194.
    Fitzpatrick M. Leptin and the obesity hypoventilation syndrome: a leap of faith? Thorax. 2002;57:1–2.PubMedGoogle Scholar
  195. 195.
    Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999;100:706–12.PubMedGoogle Scholar
  196. 196.
    Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Collins B, Basta M, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest. 2008;38:585–95.PubMedGoogle Scholar
  197. 197.
    Tangel DJ, Mezzanotte WS, Sandberg EJ, White DP. Influences of NREM sleep on the activity of tonic vs. inspiratory phasic muscles in normal men. J Appl Physiol. 1992;73: 1058–66.PubMedGoogle Scholar
  198. 198.
    Henson LC, Ward DS. Effects of anaesthetics and sedatives on the control of breathing. Ann Acad Med Singapore. 1994;23:125–9.PubMedGoogle Scholar
  199. 199.
    Wheatley JR, Mezzanotte WS, Tangel DJ, White DP. Influence of sleep on genioglossus muscle activation by negative pressure in normal men. Am Rev Respir Dis. 1993;148:597–605.PubMedGoogle Scholar
  200. 200.
    Redline S, Tosteson T, Tishler PV, Carskadon MA, Millman RP, Milliman RP. Studies in the genetics of obstructive sleep apnea. Familial aggregation of symptoms associated with sleep-related breathing disturbances. Am Rev Respir Dis. 1992;145:440–4.PubMedGoogle Scholar
  201. 201.
    Pillar G, Lavie P. Assessment of the role of inheritance in sleep apnea syndrome. Am J Respir Crit Care Med. 1995;151:688–91.PubMedGoogle Scholar
  202. 202.
    Redline S, Tishler PV, Tosteson TD, Williamson J, Kump K, Browner I, et al. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med. 1995;151:682–7.PubMedGoogle Scholar
  203. 203.
    Carmelli D, Bliwise DL, Swan GE, Reed T. Genetic factors in self-reported snoring and excessive daytime sleepiness: a twin study. Am J Respir Crit Care Med. 2001;164:949–52.PubMedGoogle Scholar
  204. 204.
    Patel SR. Shared genetic risk factors for obstructive sleep apnea and obesity. J Appl Physiol. 2005;99:1600–6.PubMedGoogle Scholar
  205. 205.
    Schwab RJ. Genetic determinants of upper airway structure that predispose to obstructive sleep apnea. Respir Physiol Neurobiol. 2005;147:289–98.PubMedGoogle Scholar
  206. 206.
    Riha RL. Genetic aspects of the obstructive sleep apnoea-hypopnoea syndrome. Somnologie. 2006;10:101–12.Google Scholar
  207. 207.
    Schwab RJ, Pasirstein M, Kaplan L, Pierson R, Mackley A, Hachadoorian R, et al. Family aggregation of upper airway soft tissue structures in normal subjects and patients with sleep apnea. Am J Respir Crit Care Med. 2006;173:453–63.PubMedGoogle Scholar
  208. 208.
    Patel SR, Larkin EK, Redline S. Shared genetic basis for obstructive sleep apnea and adiposity measures. Int J Obes (Lond). 2008;32:795–800.Google Scholar
  209. 209.
    Holberg CJ, Natrajan S, Cline MG, Quan SF. Familial aggregation and segregation analysis of snoring and symptoms of obstructive sleep apnea. Sleep Breath. 2000;4:21–30.PubMedGoogle Scholar
  210. 210.
    Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med. 2003;254:32–44.PubMedGoogle Scholar
  211. 211.
    Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev. 2005;9:211–24.PubMedGoogle Scholar
  212. 212.
    Harsch IA, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Schahin SP, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J. 2003;22:251–7.PubMedGoogle Scholar
  213. 213.
    Takahashi K, Chin K, Akamizu T, Morita S, Sumi K, Oga T, et al. Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment. Respirology. 2008;13:810–6.PubMedGoogle Scholar
  214. 214.
    Morgenthaler TI, Kapen S, Lee-Chiong T, Alessi C, Boehlecke B, Brown T, et al. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep. 2006;29:1031–5.PubMedGoogle Scholar
  215. 215.
    Nerfeldt P, Nilsson BY, Mayor L, Udden J, Friberg D. A two-year weight reduction program in obese sleep apnea patients. J Clin Sleep Med. 2010;6:479–86.PubMedGoogle Scholar
  216. 216.
    Monteforte MJ, Turkelson CM. Bariatric surgery for morbid obesity. Obes Surg. 2000;10: 391–401.PubMedGoogle Scholar
  217. 217.
    Sugerman HJ. Bariatric surgery for severe obesity. J Assoc Acad Minor Phys. 2001;12: 129–36.PubMedGoogle Scholar
  218. 218.
    Charuzi I, Lavie P, Peiser J, Peled R. Bariatric surgery in morbidly obese sleep-apnea patients: short- and long-term follow-up. Am J Clin Nutr. 1992;55:594S–6.PubMedGoogle Scholar
  219. 219.
    Aubert-Tulkens G, Culee C, Rodenstein DO. Cure of sleep apnea syndrome after long-term nasal continuous positive airway pressure therapy and weight loss. Sleep. 1989;12:216–22.PubMedGoogle Scholar
  220. 220.
    Browman CP, Sampson MG, Yolles SF, Gujavarty KS, Weiler SJ, Walsleben JA, et al. Obstructive sleep apnea and body weight. Chest. 1984;85:435–8.PubMedGoogle Scholar
  221. 221.
    Dixon JB, Schachter LM, O’Brien PE. Polysomnography before and after weight loss in obese patients with severe sleep apnea. Int J Obes (Lond). 2005;29:1048–54.Google Scholar
  222. 222.
    Harman EM, Wynne JW, Block AJ. The effect of weight loss on sleep-disordered breathing and oxygen desaturation in morbidly obese men. Chest. 1982;82:291–4.PubMedGoogle Scholar
  223. 223.
    Smith PL, Gold AR, Meyers DA, Haponik EF, Bleecker ER. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med. 1985;103:850–5.PubMedGoogle Scholar
  224. 224.
    Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep. 1996;19:104–15.PubMedGoogle Scholar
  225. 225.
    Suratt PM, McTier RF, Findley LJ, Pohl SL, Wilhoit SC. Changes in breathing and the pharynx after weight loss in obstructive sleep apnea. Chest. 1987;92:631–7.PubMedGoogle Scholar
  226. 226.
    Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard RD, Magalang UJ. Medical therapy for obstructive sleep apnea: a review by the medical therapy for obstructive sleep apnea task force of the Standards of practice committee of the American academy of sleep medicine. Sleep. 2006;29:1036–44.PubMedGoogle Scholar
  227. 227.
    Serafini FM, MacDowell AW, Rosemurgy AS, Strait T, Murr MM. Clinical predictors of sleep apnea in patients undergoing bariatric surgery. Obes Surg. 2001;11:28–31.PubMedGoogle Scholar
  228. 228.
    Busetto L, Tregnaghi A, Bussolotto M, Sergi G, Beninca P, Ceccon A, et al. Visceral fat loss evaluated by total body magnetic resonance imaging in obese women operated with laparoscopic adjustable silicone gastric banding. Int J Obes Relat Metab Disord. 2000;24:60–9.PubMedGoogle Scholar
  229. 229.
    Huerta S, DeShields S, Shpiner R, Li Z, Liu C, Sawicki M, et al. Safety and efficacy of postoperative continuous positive airway pressure to prevent pulmonary complications after Roux-en-Y gastric bypass. J Gastrointest Surg. 2002;6:354–8.PubMedGoogle Scholar
  230. 230.
    Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346: 1623–30.PubMedGoogle Scholar
  231. 231.
    Balsiger BM, Kennedy FP, Abu-Lebdeh HS, Collazo-Clavell M, Jensen MD, O’Brien T, et al. Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity. Mayo Clin Proc. 2000;75:673–80.PubMedGoogle Scholar
  232. 232.
    Bouldin MJ, Ross LA, Sumrall CD, Loustalot FV, Low AK, Land KK. The effect of obesity surgery on obesity comorbidity. Am J Med Sci. 2006;331:183–93.PubMedGoogle Scholar
  233. 233.
    Charuzi I, Fraser D, Peiser J, Ovnat A, Lavie P. Sleep apnea syndrome in the morbidly obese undergoing bariatric surgery. Gastroenterol Clin North Am. 1987;16:517–9.PubMedGoogle Scholar
  234. 234.
    Fritscher LG, Mottin CC, Canani S, Chatkin JM. Obesity and obstructive sleep apnea-hypopnea syndrome: the impact of bariatric surgery. Obes Surg. 2007;17:95–9.PubMedGoogle Scholar
  235. 235.
    Haines KL, Nelson LG, Gonzalez R, Torrella T, Martin T, Kandil A, et al. Objective evidence that bariatric surgery improves obesity-related obstructive sleep apnea. Surgery. 2007;141: 354–8.PubMedGoogle Scholar
  236. 236.
    Kalra M, Inge T. Effect of bariatric surgery on obstructive sleep apnoea in adolescents. Paediatr Respir Rev. 2006;7:260–7.PubMedGoogle Scholar
  237. 237.
    Kushner RF, Noble CA. Long-term outcome of bariatric surgery: an interim analysis. Mayo Clin Proc. 2006;81:S46–51.PubMedGoogle Scholar
  238. 238.
    Lankford DA, Proctor CD, Richard R. Continuous positive airway pressure (CPAP) changes in bariatric surgery patients undergoing rapid weight loss. Obes Surg. 2005;15:336–41.PubMedGoogle Scholar
  239. 239.
    Loube DI, Loube AA, Mitler MM. Weight loss for obstructive sleep apnea: the optimal therapy for obese patients. J Am Diet Assoc. 1994;94:1291–5.PubMedGoogle Scholar
  240. 240.
    Scheuller M, Weider D. Bariatric surgery for treatment of sleep apnea syndrome in 15 morbidly obese patients: long-term results. Otolaryngol Head Neck Surg. 2001;125:299–302.PubMedGoogle Scholar
  241. 241.
    Spivak H, Hewitt MF, Onn A, Half EE. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. Am J Surg. 2005;189:27–32.PubMedGoogle Scholar
  242. 242.
    Valencia-Flores M, Orea A, Herrera M, Santiago V, Rebollar V, Castano VA, et al. Effect of bariatric surgery on obstructive sleep apnea and hypopnea syndrome, electrocardiogram, and pulmonary arterial pressure. Obes Surg. 2004;14:755–62.PubMedGoogle Scholar
  243. 243.
    Verse T. Bariatric surgery for obstructive sleep apnea. Chest. 2005;128:485–7.PubMedGoogle Scholar
  244. 244.
    Patil SP, Schneider H, Marx JJ, Gladmon E, Schwartz AR, Smith PL. Neuromechanical control of upper airway patency during sleep. J Appl Physiol. 2007;102:547–56.PubMedGoogle Scholar
  245. 245.
    Holdstock C, Engstrom BE, Ohrvall M, Lind L, Sundbom M, Karlsson FA. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab. 2003;88:3177–83.PubMedGoogle Scholar
  246. 246.
    Li C, Ioffe E, Fidahusein N, Connolly E, Friedman JM. Absence of soluble leptin receptor in plasma from dbPas/dbPas and other db/db mice. J Biol Chem. 1998;273:10078–82.PubMedGoogle Scholar
  247. 247.
    Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003;88:1594–602.PubMedGoogle Scholar
  248. 248.
    Ott V, Fasshauer M, Dalski A, Meier B, Perwitz N, Klein HH, et al. Direct peripheral effects of ghrelin include suppression of adiponectin expression. Horm Metab Res. 2002;34:640–5.PubMedGoogle Scholar
  249. 249.
    Whitson BA, Leslie DB, Kellogg TA, Maddaus MA, Buchwald H, Billington CJ, et al. Adipokine response in diabetics and nondiabetics following the roux-en-y gastric bypass: a preliminary study. J Surg Res. 2007;142:295–300.PubMedGoogle Scholar
  250. 250.
    Rasheid S, Banasiak M, Gallagher SF, Lipska A, Kaba S, Ventimiglia D, et al. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg. 2003;13:58–61.PubMedGoogle Scholar
  251. 251.
    Guardiano SA, Scott JA, Ware JC, Schechner SA. The long-term results of gastric bypass on indexes of sleep apnea. Chest. 2003;124:1615–9.PubMedGoogle Scholar
  252. 252.
    Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Division of Pulmonary and Critical Care MedicineJohns Hopkins School of MedicineBaltimoreUSA
  2. 2.Division of Pulmonary and Critical Care MedicineJohns Hopkins School of MedicineBaltimoreUSA

Personalised recommendations